Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Recipient : GATC Health
Deal Size : Undisclosed
Deal Type : Collaboration
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA Therapeutics
Details : The collaboration is designed to enhance the design, delivery, and targeting of Circurna’s next-generation RNA therapeutics.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
August 26, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Recipient : GATC Health
Deal Size : Undisclosed
Deal Type : Collaboration